About us

Biosystems International Kft. (BSI) is an in-vitro diagnostics R&D company founded in 2005.

BSI deploys a unique and protected protein epitome profiling technology platform for the discovery and development of disease specific plasma protein epitope panels (multivariate index assays). The diagnostics are enabled to run on popular validated protein array and ELISA platforms. (see news)

To speed discovery to market time, we license or sell our Dx candidates to industrial partners present on the global market. In parallel, BSI offers special laboratory services using its mAb proteomics technologies.

Partners

Randox Laboratories is an international clinical diagnostic and life science technology company. Randox develops, manufactures and markets diagnostic reagents and equipment for laboratory medicine, with a distribution network of 130 countries.

Ipsen is a French pharmaceutical company headquartered in Paris, France. It primarily develops and markets medications used in oncology,endocrinology and the treatment of neuromuscular disorders. It is publicly traded on the Euronext Paris.

Targetex is a Hungarian R&D company supporting medical activity with a focus on molecular biology and biotechnology.

UD-GENOMED is a complex genomics R&D service provider company.